China's drug regulator granted Yabao Pharmaceutical's (SHA:600351) Beijing subsidiary a drug registration certificate for its ezetimibe tablets, according to a Saturday filing with the Shanghai bourse.
Beijing Yabao Biopharmaceutical's drug treats high cholesterol levels by absorbing cholesterol in the intestine, the pharmaceutical company said in its filing.
Sical Logistics (BOM:SICAILOG, NSE:520086) board approved availing credit facilities of up to 1.15 billion Indian rupees from Axis Bank (NSE:AXISBANK, BOM:532215), according to a Saturday filing on Indian bourses.Shares of the company rose over 4% in Monday's trade.The package includes a cash credit facility of up to 150 million rupees, a bank guarantee facility of up to 150 million rupees, and a term loan refinancing facility of up to 850 million rupees, the filing said.
China's drug regulator approved Beijing Wandong Medical Technology's (SHA:600055) X-ray machine for medical angiography, according to a Saturday filing with the Shanghai bourse.The approval is valid for five years, until May 18, 2031.
China's drug regulator approved Chongqing Taiji Industry's (SHA:600129) supplementary drug application for its digoxin injection, according to a Saturday filing with the Shanghai bourse.The injection helps treat mild to moderate heart failure in adults and increases cardiac force in children with heart failure, the filing said.